US2014024622A1PendingUtilityA1

Compositions comprising tramadol and celecoxib in the treatment of pain

Assignee: ESTEVE LABOR DRPriority: Oct 16, 2009Filed: Sep 25, 2013Published: Jan 23, 2014
Est. expiryOct 16, 2029(~3.2 yrs left)· nominal 20-yr term from priority
A61P 25/02A61P 25/04A61P 25/00A61P 29/00A61P 21/00A61P 19/02A61P 19/08A61K 31/085A61K 45/06A61K 31/415A61K 31/635A61K 31/135A61K 31/137A61K 31/015A61K 31/05
40
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to pharmaceutical compositions comprising tramadol and celecoxib and their uses as medicaments or analgesics, more particularly for the treatment of severe to moderate pain with an inflammation component.

Claims

exact text as granted — not AI-modified
1 . A pharmaceutical composition comprising a synergistic combination of (rac)-tramadol.HCl and celecoxib or a pharmaceutically acceptable salt or hydrate thereof, wherein the molecular ratio of the (rac)-tramadol.HCl to the celecoxib is a molar ratio of from about 1:1 to about 1:3 or from about 1:1 to about 3:1. 
     
     
         2 . A pharmaceutical composition according to  claim 1 , wherein the molecular ratio of the (rac)-tramadol.HCl to the celecoxib is a molar ratio of about 3:1. 
     
     
         3 . A pharmaceutical composition according to  claim 1 , wherein the molecular ratio of the (rac)-tramadol.HCl to the celecoxib is a molar ratio of about 1:3. 
     
     
         4 . A pharmaceutical composition according to  claim 1 , wherein the molecular ratio of the (rac)-tramadol.HCl to the celecoxib is a molar ratio of about 1:1. 
     
     
         5 . A pharmaceutical composition according to  claim 1 , wherein the celecoxib is in neutral form. 
     
     
         6 . A pharmaceutical composition according to  claim 1 , wherein the composition is a liquid composition. 
     
     
         7 . A method for the treatment of pain comprising administering to a subject in need thereof a therapeutically effective amount of at least one pharmaceutical composition according to  claim 1 . 
     
     
         8 . A method according to  claim 7 , wherein said pain is selected from acute pain, chronic pain, neuropathic pain, nociceptive pain, mild and severe to moderate pain, hyperalgesia, pain related to central sensitization, allodynia or cancer pain, diabetic neuropathy, diabetic peripheral neuropathy, osteoarthritis, fibromyalgia, rheumatoid arthritis, ankylosing spondylitis, frozen shoulder and sciatica.

Join the waitlist — get patent alerts

Track US2014024622A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.